Scholars Central

Conference abstractPublished 23 Nov 2012

Bioinformatics, drugs and omics- An overview of the major areas of the omics

Authors: S. M. Zahid Hosen

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Bioinformatics is becoming more and more important in drug discovery and drug development and is tightly integrated with various omics technologies and other high through throughput technologies. The automated omics technologies which have followed the genomics revolution generate very large amounts of data, and it is the task of bioinformatics to take care of these data and make practical use of them. Omics is used in words such as genomics, transcriptomics, proteomics, metabolomics, and interactomics. Omics produces very large amount of data and these data accumulate at an ever increasing speed. The amounts of data are so large that it is impossible for a human brain to encompass even a tiny fraction of them and even if we could, making practical use of them would be an even more difficult task. It is evident therefore that computers are needed to translate the data into formats that can be understood and interpreted by humans. In this study we have concentrated on describing the methods for data acquisition in omics and some features of the underlying biology that are essential for interpreting the results from the data generated . Omics technologies thus aim at studying the organism in their entirety. Based on the knowledge gained it is hoped that we will be able to develop drug faster and more efficiently.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pharmaceutical Regulatory Affairs: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Regulatory Affairs: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “S. M. Zahid Hosen”